Study proposes ‘liquid-biopsy-like’ alternative to determine cardiometabolic risk in in patients living with obesity

Obesity levels worldwide are rising and therefore, personalized care is becoming paramount. At the same time, scientists believe that not all fat is the same. Previous studies have shown that measuring levels of visceral adipose tissue (VAT) inflammation gives a good approximation of cardiometabolic risk. However, currently VAT inflammation cannot be measured without invasive surgery. Now, Ben-Gurion University of the Negev scientists have proposed a “liquid-biopsy-like” alternative to surgery by measuring circulating miRNAs. They found that the combined levels of two or three circulating miRNAs was a good indication of high VAT inflammation. Their findings were published in the March Read More